232 related articles for article (PubMed ID: 18789848)
1. Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases.
Vázquez MF; Romero ED; García MI; Rodríguez JA; Bellido JL
Int J Antimicrob Agents; 2008 Dec; 32(6):541-3. PubMed ID: 18789848
[No Abstract] [Full Text] [Related]
2. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Conejo MC; Hernández JR; Pascual A
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
4. Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Lu CT; Chuang YC; Sun W; Liu YC; Cheng YJ; Lu PL; Chen CM; Hsu GJ; Jang TN; Lee CM; Chiang PC; Shi ZY; Wang LS; Kung HC; Lin HC; Liao CH; Liu JW; Huang CH; Tsao SM; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S179-83. PubMed ID: 19013351
[TBL] [Abstract][Full Text] [Related]
5. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
6. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
8. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England.
Hope R; Warner M; Potz NA; Fagan EJ; James D; Livermore DM
J Antimicrob Chemother; 2006 Dec; 58(6):1312-4. PubMed ID: 17035342
[No Abstract] [Full Text] [Related]
9. In vitro activity of tigecycline against metallo-beta-lactamase-producing Enterobacteriaceae.
Pliatsika V; Afkou Z; Protonotariou E; Sofianou D
J Antimicrob Chemother; 2007 Dec; 60(6):1406-7. PubMed ID: 17962216
[No Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
Hoban DJ; Bouchillon SK; Dowzicky MJ
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
[TBL] [Abstract][Full Text] [Related]
11. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
12. [Molecular characterization of extended-spectrum ss-lactamases-producing Escherichia coli and Klebsiella pneumoniae in hospitals of the Caribean Region, Colombia].
Gaitán C SL; Espinal M PA
Rev Chilena Infectol; 2009 Jun; 26(3):239-46. PubMed ID: 19621157
[TBL] [Abstract][Full Text] [Related]
13. Metallo-β-lactamase-producing Enterobacteriaceae isolates at a Taiwanese hospital: lack of distinctive phenotypes for screening.
Liao IC; Chen HM; Wu JJ; Tsai PF; Wang LR; Yan JJ
APMIS; 2011 Aug; 119(8):543-50. PubMed ID: 21749455
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.
Silva-Sanchez J; Reyna-Flores F; Velazquez-Meza ME; Rojas-Moreno T; Benitez-Diaz A; Sanchez-Perez A;
Diagn Microbiol Infect Dis; 2011 Jun; 70(2):270-3. PubMed ID: 21596226
[TBL] [Abstract][Full Text] [Related]
15. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Vourli S; Giakkoupi P; Miriagou V; Tzelepi E; Vatopoulos AC; Tzouvelekis LS
FEMS Microbiol Lett; 2004 May; 234(2):209-13. PubMed ID: 15135524
[TBL] [Abstract][Full Text] [Related]
16. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
DiPersio JR; Dowzicky MJ
Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
[TBL] [Abstract][Full Text] [Related]
17. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli in Granada, Spain.
Sorlózano A; Gutiérrez J; Salmerón A; Luna JD; Martínez-Checa F; Román J; Piédrola G
Int J Antimicrob Agents; 2006 Dec; 28(6):532-6. PubMed ID: 17045785
[TBL] [Abstract][Full Text] [Related]
18. Real-time polymerase chain reaction for rapid detection of genes encoding SHV extended-spectrum β-lactamases.
Alfaresi MS; Elkoush AA
Indian J Med Microbiol; 2010; 28(4):332-6. PubMed ID: 20966564
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Berçot B; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2008 Dec; 52(12):4526-7. PubMed ID: 18838598
[No Abstract] [Full Text] [Related]
20. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW
Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
